Wells Fargo’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Wells Fargo’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52	Sell	1 -1	-50%	-$35	﹤0.01%	6723
2026 Q1	$64	Buy	2 +1	+100%	+$34	﹤0.01%	6554
2025 Q4	$30	Hold	1	–	–	﹤0.01%	6637
2025 Q3	$29	Hold	1	–	–	﹤0.01%	6614
2025 Q2	$14	Hold	1	–	–	﹤0.01%	6857
2025 Q1	$29	Hold	1	–	–	﹤0.01%	6568
2024 Q4	$30	Buy	+1	New	+$28	﹤0.01%	6606
2024 Q3	–	Sell	-1,297	Closed	-$37.1K	–	6704
2024 Q2	$35.3K	Buy	+1,297	New	+$34.7K	﹤0.01%	5413
2024 Q1	–	Sell	-1	Closed	-$28	–	7249
2023 Q4	$20	Hold	1	–	–	﹤0.01%	7218
2023 Q3	$16	Hold	1	–	–	﹤0.01%	7278
2023 Q2	$30	Hold	1	–	–	﹤0.01%	7195
2023 Q1	$29	Hold	1	–	–	﹤0.01%	7269
2022 Q4	$27	Hold	1	–	–	﹤0.01%	7204
2022 Q3	$0	Hold	1	–	–	﹤0.01%	6881
2022 Q2	$0	Hold	1	–	–	﹤0.01%	7028
2022 Q1	$0	Sell	1 -1	-50%	-$26	﹤0.01%	7311
2021 Q4	$0	Buy	+2	New	+$53	﹤0.01%	7414
2021 Q3	–	Sell	-1	Closed	–	–	7148
2021 Q2	$0	Hold	1	–	–	﹤0.01%	7065
2021 Q1	$0	Sell	1 -1	-50%	-$26	﹤0.01%	7027
2020 Q4	$0	Buy	2 +1	+100%	+$25	﹤0.01%	6650
2020 Q3	$0	Sell	1 -1	-50%	-$24	﹤0.01%	6514
2020 Q2	$0	Hold	2	–	–	﹤0.01%	6466
2020 Q1	$0	Hold	2	–	–	﹤0.01%	6394
2019 Q4	$0	Hold	2	–	–	﹤0.01%	6484
2019 Q3	$0	Buy	2 +1	+100%	+$21	﹤0.01%	6492
2019 Q2	$0	Buy	+1	New	+$21	﹤0.01%	6444

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo's FTXH Position: Q2 2026 in Review

Wells Fargo reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 50% in Q2 2026, selling an estimated $35 and leaving 1 share worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #6723.

Wells Fargo first reported a position in FTXH in Q2 2019 and has held it in 26 quarters since. The position peaked at $35.3K in Q2 2024. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Wells Fargo held 1 share of First Trust Nasdaq Pharmaceuticals ETF worth $52 as of Q2 2026.
Wells Fargo sold 1 First Trust Nasdaq Pharmaceuticals ETF share in Q2 2026, an estimated $35.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6723 holding.
Wells Fargo first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2019 and has held it in 26 quarters since.
Wells Fargo's First Trust Nasdaq Pharmaceuticals ETF position peaked at $35.3K in Q2 2024.
30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.